Associations between human aldosterone synthase (CYP11B2) gene polymorphisms and left ventricular size, mass, and function

Circulation

Volumn 97, Issue 6, 1998, Pages 569-575

  Kupari, Markku ^a   Hautanen, Aarno ^c   Lankinen, Laura ^c   Koskinen, Pekka ^a   Virolainen, Juha ^a   Nikkila, Heli ^c   White, Perrin C ^b  

^a Division of Cardiology   (Finland)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c NONE

Author keywords

Echocardiography; Genes; Ventricles

Indexed keywords

ALDOSTERONE SYNTHASE;

ADULT; ARTICLE; ECHOCARDIOGRAPHY; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE MASS; HEART LEFT VENTRICLE SIZE; HUMAN; MALE; NORMAL HUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SALT INTAKE;

EID: 0031911098     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.97.6.569     Document Type: Article

References (38)

1. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med. 1990;322:1561-1566.
2. Lauer MS, Evans JC, Levy D. Prognostic implications of subdinical left ventricular dilatation and systolic dysfunction in men free of oven cardiovascular disease (the Framingham Heart Study). Am J Cardiol. 1992;70:1180-1184.
3. Galderisi M, Anderson KM, Wilson PW, Levy D. Echocardiographic evidence for the existence of a distinct diabetic cardiomyopathy (the Framingham Heart Study). Am J Cardiol. 1991;68:85-89.
4. Manolio TA, Levy D, Garrison RJ, Castelli WP, Kannel WB. Relation of alcohol intake to left ventricular mass: the Framingham Study. J Am Coll Cardiol. 1991;17:717-721.
5. Levy D, Anderson KM, Savage DD, Kannel WB, Christiansen JC, Castelli WP. Echocardiographically detected left ventricular hypertrophy: prevalence and risk factors: the Framingham Heart Study. Ann Intern Med. 1988;108:7-13.
6. Liebson PR, Grandits G, Prineas R, Dianzumba S, Flack JM, Cutler JA, Grimm R, Stamler J. Echocardiographic correlates of left ventricular structure among 844 mildly hypertensive men and women in the Treatment of Mild Hypertension Study (TOMHS). Circulation. 1993;87:476-486.
7. Adams TD, Yanowitz FG, Fisher AG, Ridges JD, Nelson AG, Higan AD, Williams RR, Hunt SC. Heritability of cardiac size: an echocardiographic and electrocardiographic study of monozygotic and dizygotic twins. Circulation. 1985;71:39-44.
8. Harshfield GA, Grim CE, Hwang C, Savage DD, Anderson SJ. Genetic and environmental influences on echocardiographically determined left ventricular mass in black twins. Am J Hypertens. 1990;3:538-543.
9. Bielen E, Fagard R, Amery A. Inheritance of heart structure and physical exercise capacity: a study of left ventricular structure and exercise capacity in 7-year-old twins. Eur Heart J. 1990;11:7-16.
10. Verhaaren HA, Schieken RM, Mosteller M, Hewitt JK, Eaves LJ, Nance WE. Bivariate genetic analysis of left ventricular mass and weight in pubertal twins (the Medical College of Virginia Twin Study). Am J Cardiol. 1991;68:661-668.
11. White PC. Disorders of aldosterone biosynthesis and action. N Engl J Med. 1994;331:250-258.
12. Rigat B. Hubert C, Alhenc-Gelas F. Cambien F, Corvol P. Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest. 1990;86:1343-1346.
13. Cambien F, Puirier O, Lecerf L, Evans A, Cambou JP, Arveiler D, Luc G, Bard JM, Bara L, Ricard S. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature. 1992;359:641-644.
14. Schunkert H, Hense HW, Holmer SR, Stender M. Perz S, Keil U, Lorell BH, Riegger GA. Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy. N Engl J Med. 1994;330:1634-1638.
15. Iwai N, Ohmichi N, Nakamura Y, Kinoshita M. DD genotype of the angiotensin-converting enzyme gene is a risk factor for left ventricular hypertrophy. Circulation. 1994;90:2622-2628.
16. Kupari M, Perola M, Koskinen P, Virolainen J, Karhunen PJ. Left ventricular size, mass, and function in relation to angiotensin-converting enzyme gene polymorphism in humans. Am J Physiol. 1994:267;H1107-H1111.
17. Lindpaintner K, Lee MA, Larson MG, Rao US, Pfeffer MA, Ordovas JM, Schaefer EJ, Wilson AF, Wilson PW, Vasan RS, Myers RH, Levy D. Absence of association or genetic linkage between the angiotensinconverting-enzyme gene and left ventricular mass. N Engl J Med. 1996;334:1023-1028.
18. Curnow KM, Tusie-Luna MT, Pascoe L, Natarajan R, Gu JL, Nadler JL, White PC. The product of the CYP11B2 gene is required for aldosterone biosynthesis in the human adrenal cortex. Mol Endocrinol. 1991;5:1513-1522.
19. Mornet E, Dupont J, Vitek A, White PC. Characterization of two genes encoding human steroid 11 beta-hydroxylase (P-450(11) beta). J Biol Chem. 1989;264:20961-20967.
20. Pascoe L, Curnow KM, Slutsker L, Rosier A, White PC. Mutations in the human CYP11B2 (aldosterone synthase) gene causing corticosterone methyloxidase II deficiency. Proc Natl Acad Sci U S A. 1992;89:4996-5000.
21. Lifton RP, Dluhy RG, Powers M, Rich GM, Cook S. Ulick S, Lalouel JM. A chimaeric 11 beta-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature. 1992;355:262-265.
22. Lifton RP, Dluhy RG, Powers M, Rich GM, Gutkin M, Fallo F, Gill JR Jr, Feld L, Ganguly A, Laidlaw JC, Mumaghan DJ, Kaufman C, Stockigt JR, Ulick S, Lalouel JM. Hereditary hypertension caused by chimaeric gene duplications and ectopic expression of aldosterone synthase. Nat Genet. 1992;2:66-74.
23. Pascoe L, Curnow KM, Slutsker L, Connell JM, Speiser PW, New MI, White PC. Glucocorticoid-suppressible hyperaldosteronism results from hybrid genes created by unequal crossovers between CYP11B1 and CYP11B2. Proc Natl Acad Sci U S A. 1992;89:8327-8331.
24. White PC, Slutsker L. Haplotype analysis of CYP11B2. Endocr Res. 1995; 21:437-442.
25. Kupari M, Koskinen P, Virolainen J, Correlates of left ventricular mass in a population sample aged 36 to 37 years: focus on lifestyle and salt intake. Circulation. 1994;89:1041-1050.
26. Kupari M, Koskinen P, Hynynen M, Salmenpera M, Ventila M. Acute effects of ethanol on left ventricular diastolic function. Br Heart J. 1990;64: 129-132.
27. Kupari M. Reproducibility of M-mode echocardiographic assessment of left ventricular function: significance of the temporal range of measurements. Eur Heart J. 1984;5:412-418.
28. Sullivan JM, Ratts TE, Schoenberger AA, Samaha JK, Palmer ET. The effect of diet on echocardiographic left ventricular dimensions in normal man. Am J Clin Nutr. 1979;32:2410-2415.
29. Ferrara LA, de Simone G, Pasanisi F, Mancini M. Left ventricular mass reduction during salt depletion in arterial hypertension. Hypertension. 1984; 6:755-759.
30. Brilla CG, Matsubara LS, Weber KT. Anti-aldosterone treatment and the prevention of myocardial fibrosis in primary and secondary hyperaldosteronism. J Mol Cell Cardiol. 1993;25:563-575.
31. Young M, Fullerton MJ, Dilley R, Funder JW. Mineralocorticoids, hypertension and cardiac fibrosis. J Clin Invest. 1994;93:2578-2583.
32. Edwards CR, Stewart PM, Burt D, Brett L, McIntyre MA, Sutanto WS, de Kloet ER, Monder C. Localisation of 11 beta-hydroxysteroid dehydrogenase-tissue specific protector of the mineralocorticoid receptor. Lancet. 1988;2:986-989.
33. Funder JW, Pearce PT, Smith R, Smith AI. Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated. Science. 1988;242:583-585.
34. Lombes M, Alfaidy N, Eugene E, Lessana A, Farman N, Bonvalet JP. Prerequisite for cardiac aldosterone action: mineralocorticoid receptor and 11 beta-hydroxysteroid dehydrogenase in the human heart. Circulation. 1995;92:175-182.
35. +-dependent 11β-hydroxysteroid dehydrogenase in the human heart. J Mol Cell Cardiol 1996;28:781-787.
36. Lala DS, Rice DA, Parker KL. Steroidogenic factor I, a key regulator of steroidogenic enzyme expression, is the mouse homolog of fushi tarazufactor I. Mol Endocrinol. 1992;6:1249-1258.
37. Clyne CD, Zhang Y, Slutsker L, Mathis JM, White PC, Rainey WE. Angiotensin II and potassium regulate human CYP11B2 transcription through common cis elements. Mol Endocrinol. 1997;11:638-649.
38. Globerman H, Rosler A, Theodor R, New MI, White PC. An inherited defect in aldosterone biosynthesis caused by a mutation in or near the gene for steroid 11-hydroxylase. N Engl J Med. 1988;319:1193-1197.